UNICHEMLAB.NS
Unichem Laboratories Limited [UNICHEMLAB.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
UNICHEMLAB.NS Stock Summary
Top 10 Correlated ETFs
UNICHEMLAB.NS
Top 10 Correlated Stocks
UNICHEMLAB.NS
In the News
UNICHEMLAB.NS Financial details
Company Rating
-
Market Cap
38.2B
Income
145.69M
Revenue
16.75B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
2.89K
Optionable
No
Shortable
Yes
Earnings
21 May 2024
P/E
-23.55
Forward P/E
-
PEG
4.2
P/S
2.04
P/B
1.3
P/C
-
P/FCF
-
Quick Ratio
1.24
Current Ratio
2.77
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.07
EPS next Y
-
EPS next Q
-
EPS this Y
-711.06%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
53.41%
Revenue last 5Y
3.65%
Revenue Q/Q
4.51%
EPS Q/Q
-442.82%
-
-
-
-
SMA20
-8.61%
SMA50
-13.34%
SMA100
-25.81%
Inst Own
-
Inst Trans
-
ROA
-4%
ROE
-5%
ROC
-0.04%
Gross Margin
58%
Oper. Margin
-7%
Profit Margin
-9%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
366.4-572.0
52W High
+5.31%
52W Low
+64.59%
RSI
40.97
Rel Volume
0.19
Avg Volume
80.34K
Volume
14.89K
Perf Week
-4.97%
Perf Month
-8.75%
Perf Quarter
-29.52%
Perf Half Y
-24.15%
-
-
-
-
Beta
0.141
-
-
Volatility
14.94%, 40.97%
Prev Close
-1.58%
Price
602.4
Change
-4.14%
Company Profile
- Volume Average 80.34K
- Market Capitalization 38.2B
- Employee 2.89K
- CEO Mr. Scott B. Delaney
- Headquarters Mumbai,IN
- IPO Date 2002-07-01
-
Website
https://www.unichemlabs.com 
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. It offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients, as well as contract manufacturing services. The company was founded in 1944 and is headquartered in Mumbai, India.
